Abstract
The series of papers in this thematic issue discuss the differences and similarities of foods versus drugs in disease prevention and treatment. The main focus of each contribution is considered in this review. The use as well as advantages and drawbacks of combination therapy employing drugs and foods are also elaborated on. Examples of combining the use of pharmaceuticals and food bioactives including using statins or ezetimibe in conjunction with plant sterols are provided. In summary, the present paper makes a case for adoption of food bioactives in both prevention and treatment approaches to disease, and recommends that functional foods can serve as efficacious adjuncts to pharmacotherapy during all stages of treatment of numerous diseases.
Keywords: Bioactives, drugs, food, functional foods, health promotion, mechanisms of action, genes, health, nutrigenomics, targets
Current Pediatric Reviews
Title:Foods versus Drugs for Health Promotion: Considerations for Future Directions
Volume: 8 Issue: 3
Author(s): Peter J.H. Jones and Stephanie Jew
Affiliation:
Keywords: Bioactives, drugs, food, functional foods, health promotion, mechanisms of action, genes, health, nutrigenomics, targets
Abstract: The series of papers in this thematic issue discuss the differences and similarities of foods versus drugs in disease prevention and treatment. The main focus of each contribution is considered in this review. The use as well as advantages and drawbacks of combination therapy employing drugs and foods are also elaborated on. Examples of combining the use of pharmaceuticals and food bioactives including using statins or ezetimibe in conjunction with plant sterols are provided. In summary, the present paper makes a case for adoption of food bioactives in both prevention and treatment approaches to disease, and recommends that functional foods can serve as efficacious adjuncts to pharmacotherapy during all stages of treatment of numerous diseases.
Export Options
About this article
Cite this article as:
J.H. Jones Peter and Jew Stephanie, Foods versus Drugs for Health Promotion: Considerations for Future Directions, Current Pediatric Reviews 2012; 8 (3) . https://dx.doi.org/10.2174/157339612802139460
DOI https://dx.doi.org/10.2174/157339612802139460 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gender Disparity in Lipid Target Achievements in High and Very High Atherosclerotic Cardiovascular Disease Risk Patients in the Arabian Gulf
Current Vascular Pharmacology HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design Why are People with “Poor Lung Function” At Increased Atherothrombotic Risk?A Critical Review with Potential Therapeutic Indications
Current Vascular Pharmacology Arsenic Immunotoxicity and Immunomodulation by Phytochemicals: Potential Relations to Develop Chemopreventive Approaches
Recent Patents on Inflammation & Allergy Drug Discovery Heart Failure in Minority Populations - Impediments to Optimal Treatment in Australian Aborigines
Current Cardiology Reviews Dendrimers as an Effective Nanocarrier in Cardiovascular Disease
Current Pharmaceutical Design Complications of Diabetes: An Insight into Genetic Polymorphism and Role of Insulin
Recent Patents on Inflammation & Allergy Drug Discovery The Journey of the Non-Vascular Relief for Migraine: From ‘Triptans’ To ‘Ditans’
Current Clinical Pharmacology From Antidepressant Drugs to Beta-Mimetics: Preclinical Insights on Potential New Treatments for Neuropathic Pain
Recent Patents on CNS Drug Discovery (Discontinued) Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models
Current Neuropharmacology Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer’s Disease: A Phase 2, Open-Label Extension Study
Current Alzheimer Research The Association between Metabolic Syndrome and Serum Levels of Adiponectin and High Sensitive C Reactive Protein in Gorgan
Endocrine, Metabolic & Immune Disorders - Drug Targets Significant Correlation between Cystatin C, Cerebral Infarction, and Potential Biomarker for Increased Risk of Stroke
Current Neurovascular Research Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol
Current Drug Metabolism Heart Failure and Diabetes: Perspective of a Dangerous Association
Current Hypertension Reviews Infection, its Treatment and the Risk for Stroke
Current Vascular Pharmacology Novel Drug Targets for the Treatment of Cardiac Diseases
Current Pharmacogenomics and Personalized Medicine Meet Our Editorial Board Member
Current Drug Delivery Tea and Health: Studies in Humans
Current Pharmaceutical Design Loading of Propranolol Hydrochloride on MCF and Sustained Release
Micro and Nanosystems